Scout | Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)

This grant aims to support research exploring how the human microbiome affects the immune system's response to tumors, either by enhancing or inhibiting it. The goal is to find new molecular targets for preventing cancer. Applicants should focus on how interactions between specific microbes or their metabolites with the host impact immune responses relating to tumor formation. The research sho…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Opportunity Released: November 3, 2021

Open for Submission: November 3, 2021

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

Microbiome

Cancer Prevention

Anti-tumor Immune Responses

Molecular Targets

Inflammation-associated Tumors

Sporadic Tumor Formation

Microbes and Immune System

Beneficial Microbes

Tumor Microenvironment

Host-microbe Interactions

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers